Skip to main content

Advertisement

Table 1 Clinical characteristics at baseline and CGMS features of study participants

From: Association of silent hypoglycemia with cardiac events in non-diabetic subjects with acute myocardial infarction undergoing primary percutaneous coronary interventions

Parameter value
Subject number 164
Age (years) 53 ± 15
Males 115(70)
BMI, kg/m2 24.7 ± 4.1
LVEF, % 54.2 ± 7.4
HbA1c (%) 5.1 ± 1.0
Glycated albumin (%) 12.8 ± 4.6
Oral beta-blocker therapy(n,%) 135(82.3)
Risk factors (n,%)  
Hyperlipidemia 61(37.2)
Hypertension 65(39.6)
Current smoking 76(46.3)
Family history 21(13)
Obesity 35(21)
CGMS parameters  
MBG(mmol/l) 6.6 ± 0.8
MAGE (mmol/l) 2.8 ± 1.6
SDBG(mmol/l) 1.4 ± 0.5
The number of Mean episodes of hypoglycemia per patient 1.7 ± 1.8
The numberof Mean episodes of hyperglycemia per patient 2.4 ± 2.7
Mean duration of hypoglycemia per patient (h) 1.6 ± 3.0
Mean duration of hyperglycemia per patient (h) 2.5 ± 3.9
Angiographic data (n,%)  
Single vessel 71(43.3)
Double vessels 50(30.5)
Triple vessels 43(26.2)
Main stem involved 20(12)
Multivessel 93(57)
  1. Data given as mean ± SD or n (%)
  2. BMI body mass index, LVEF left ventricularejectionfraction, HbA1c Hemoglobin A1c, MBG Mean blood glucose, MAGE the mean amplitude of glycemic excursions, SDBG the standard deviation of blood glucose values